Latest

Market news by symbol, source, and language

20 stories
business_wire

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and targeted therapeutics, today announced a collaboration with Pictor®, Inc., a targeted proteomic platform company, to support development and commercialization of bioAffinity Te…

BusinessWire en
ETFsStocksUS

REG - Nomura Intl. PLC MITIE Group PLC - Form 8.3 - MITIE GROUP PLC

RNS Number : 4454N Nomura International PLC 22 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION2.         POSITIONS OF THE PERSON M…

London Stock Exchange en
StocksGB

REG - JPMorgan Asset Mngt Prologis, Inc. - Form 8.3-Prologis, Inc

RNS Number : 4453N JPMorgan Asset Management 22 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% ORMORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLO…

London Stock Exchange en
StocksGBUS
thenewswire

Ventripoint Engages More Capital Ltd.

(TheNewswire)Pioneering Medical AI Company Moves to Increase Awareness of VMS+ System and Proprietary Knowledge Based Reconstruction TechnologyToronto, Ontario – TheNewswire – July 22, 2026 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTC:VPTDF) a pioneer in advanced…

TheNewswire en
StocksCA
business_wire

Stem Announces Second Quarter 2026 Earnings Results Conference Call

Stem, Inc. (“Stem,” “we,” or the “Company”) (NYSE: STEM), a global leader in AI-enabled clean energy software and services, today announced it will hold a conference call on Wednesday, August 12, 2026, to discuss its financial results for the quarter ended June 30, 2026.The conference call is sched…

BusinessWire en
StocksUS

REG - JPMorgan Asset Mngt SEGRO PLC - Form 8.3-SEGRO plc

RNS Number : 4446N JPMorgan Asset Management 22 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% ORMORERule 8.3 of the Takeover Code (the "Code")1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLO…

London Stock Exchange en
StocksGB

REG - Keyridge Asset Mgmnt DCC Energy PLC - Form 8.3 - DCC Energy Plc

RNS Number : 4444N Keyridge Asset Management Limited 22 July 2026  Ap27FORM 8.3IRISH TAKEOVER PANELOPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE1…

London Stock Exchange en
StocksGB
tradingview

Casey Tansey to Retire from Inspire's Board, Effective July 30, 2026

Inspire Medical Systems announced that director Casey Tansey will retire from the board effective July 30, 2026, and will not stand for re-election at the 2027 Annual Meeting.Original SEC Filing: Inspire Medical Systems, Inc. [ INSP ] - 8-K - Jul. 22, 2026This is an AI-powered summary. It may conta…

TradingView en
StocksUS
tradingview

Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease

Monopar initiated a rolling New Drug Application submission to the FDA for ALXN1840 in Wilson disease, submitting initial completed sections.Key Highlights:Original SEC Filing: Monopar Therapeutics [ MNPR ] - 8-K - Jul. 22, 2026This is an AI-powered summary. It may contain inaccuracies. Consider ve…

TradingView en
StocksUS
NEWS financewire

ArkBridge Launches Institutional Intelligence Platform for Modern Investors

London, United Kingdom, July 22nd, 2026, FinanceWireNew AI-Powered Multi-Asset Trading and Wealth Management Platform Built to Bridge Global MarketsRichard Ashford, Chief Investment Officer at ArkBridge, discusses the growing role of AI in modern investing.ArkBridge, a new multi-asset trading and w…

FinanceWire en
ETFs
prnewswire

Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria

Nu-3, a Phase 2-ready candidate targeting the treatment of infected diabetic foot ulcers (iDFU), targets disruption of bacterial membranes through a unique, physical mechanism of action and has demonstrated a high barrier to resistance.SARASOTA, Fla., July 22, 2026 /PRNewswire/ -- Lakewood-Amedex B…

PR Newswire en
StocksUS

REG - Lindsell Train Ltd Intertek Group Plc - Form 8.3 Intertek Group plc

RNS Number : 4441N Lindsell Train Limited 22 July 2026  FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the "Code")1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAK…

London Stock Exchange en
StocksGB